The Nobel Assembly at Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning
Nordic Life Science
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
Alder Therapeutics is a newly founded preclinical phase stem cell therapy development company with the goal to reshape the cell therapy sector with a novel, reduced-risk approach and two cell
NorthX Biologics has announced the official inauguration of its Innovation Hub at the Matfors facility. This milestone marks a major step forward in NorthX’s commitment to the field of advanced
Abera Bioscience begins cooperation with three strategic investors and in connection with this, the board has decided to carry out a directed new share issue of 1,555,556 shares at a
The company carries out a directed share issue to a limited number of current shareholders in the company, such as Gerald Engström who, following the Share Issue, becomes the largest
With this acquisition Scantox has nearly 200 employees across four sites. “Scantox embarked on an ambitious growth journey when we acquired the first two international companies last year, and we
The Novo Nordisk Foundation has committed up to DKK 950 million (EUR 127 million) to establish a world-class facility for the final development steps and upscaling of cell therapies for
The European Commission has granted conditional marketing authorization for TEPKINLY as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma after two or
Novo Nordisk and Valo Health have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation powered by artificial
BioArctic’s partner Eisai has announced that “LEQEMBI Intravenous Infusion” has been approved in Japan as a treatment for slowing progression of mild cognitive impairment (MCI) and mild dementia due to
It’s no secret that it’s been a challenging 12 months for the life sciences and healthcare sector. With generalist investors moving out of the public markets in 2022 after the
The two collaborators aim to develop a prophylactic vaccine based on Evaxion’s EDEN-discovered gonorrhea targets. “We are thrilled about this partnership. It offers a unique opportunity to deliver our EDEN-identified
Karolinska University Hospital’s director Björn Zoëga and Karolinska Institute’s rector Annika Östman Wernerson have signed an agreement to establish a new joint center for advanced cell, gene and tissue therapies.
Evaxion Biotech has initiated a novel pipeline program, EVX-B3, an AI-designed vaccine candidate against an undisclosed bacterial pathogen. The new vaccine project will be a collaboration between Evaxion and an
Sponsored content
Advancing cell & gene therapies, providing the promise of health
Cyto-Facto Inc. began manufacturing gene and cell preparations to meet a worldwide need for new treatments that leverage a patient’s immune system to fight disease. CF implemented the Vaisala viewLinc continuous monitoring system to ensure compliance with strict GCTP regulations.
Drug and Device Development
FluoGuide has announced results from a phase IIa trial of its lead product FG001 in lung cancer. FG001 was shown to illuminate the majority of the patients’ lung tumors and
Guard Therapeutics has announced top-line results from its AKITA study, evaluating RMC-035 for the prevention of kidney injury in open-heart surgery. Patient recruitment was prematurely stopped, and as expected the
Genmab and Seagen have announced that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who received
The 15th patient with advanced hepatocellular carcinoma (HCC) has been included in the company’s ongoing phase 2a study. The study evaluates safety and efficacy with the candidate drug fostrox in
Herantis Pharma has announced that the dosing of the healthy volunteers in part 2 of the Phase 1a clinical study has been started based on decision from the Data and
Profile
The philosophical aspect of chemistry led Morten Meldal to the field and he loves, and cannot help thinking about, the next solution and the intriguing questions about our being and
Iris Öhrn considers herself a cosmopolitan person, and with good reason. The investment advisor for life science at Business Region Göteborg left her native Cuba to study and work abroad
Massachusetts Institute of Technology (MIT) in the US has produced more than its share of engineers and computer scientists, but unlike many of his peers, alumnus Dr. Robert Langer, ScD,
Careers
Isa Lindgren has been intrigued by all things science since she was a child. As Manager of Analytical Development at NorthX Biologics she gets to integrate her fascination with a
SwedenBIO has appointed the co-founder and operational manager of Sprint Bioscience, Jessica Martinsson, as its new Director General. “With her entrepreneurial experience and co-founder of a life science company, SwedenBIO
Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring
Careers
As Swedish clinicians treating large numbers of asthma patients, Henrik Ljungberg and Björn Nordlund often spent time reviewing the multiple prescriptions and directives patients received from different providers after flare-ups.
JOB ALERTS
Read the latest issue of our magazine!
No 03 2023 // This issue includes an exclusive profile interview with Jonina Gudmundsdottir, the CEO of the Icelandic CDMO Coripharma, and a special report on leadership, including advice from leadership expert Pär Skoglund Finquist and Sarah Lidé, the founder of VILDA, a Swedish network for female CEOs in the life science industry.
Our hot topics in this issue are artificial intelligence in life sciences – renowned AI expert Professor Christian Guttmann shares his insight – and global trends within manufacturing of advanced biologics. In addition you may read about the vital role of venture capital in Norway, how the EU’s new pharmaceutical legislations may backfire for access to new medicines, and Niels Abel Bonde, MVA, emphasizes the importance of Nordic Research Infrastructures.
Last but not least, we have a special report on the opportunities of cross-border collaborations and we highlight the fast growing life science industry in the Baltics and the attractive US market. We also dig deeper into the history of collaboration in our Nordic region.
Venture Capital
Nordic Life Science asked Fredrik Dahl, co-founder at Colibri Ventures, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges Nordic life science
Nordic Life Science asked Claus Andersson, General Manager at Sunstone Life Science Venture, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges
Nordic Life Science asked Inka Mero, Founder and Managing Partner at Voima Ventures, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges
“Start by asking what the problem is that you are trying to solve and develop the technology, team, and plan to solve that problem – not what you can do with the technology.” – Fredrik Dahl, Colibri Ventures
Upcoming events
The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international
At this event, the pahrmaceutical, biotechnology and medical device communities come together and discuss strategies for operational success in clinical trials. OCT Nordics is the perfect platform for professionals from
BIO-Europe convenes over 5,000 attendees, representing 60 countries and 2,220+ companies, making the event the industry’s largest gathering of biopharma professionals in Europe. Digital Partnering will take place November 14–15,
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world
The latest research news from the Nordic region
Science articles
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular
The 2023 Ig Nobel Prizes celebrates for example backward reading and counting nostril hairs. The 2023 Ig Nobel Prizes were awarded at the 33rd First Annual Ig Nobel Prize ceremony,
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes. The findings are presented in the journal Nature Microbiology
Professor Jens Juul Holst has made discoveries that have strongly influenced how people with obesity or type 2 diabetes are treated today. Throughout a long career, this internationally recognized researcher
Professor Åslaug Helland is the recipient of the King Olav Vs Cancer Research Award 2023. “This is a great honor, and I am very happy about this recognition of the
In January 2023, the European Association for the Study of Obesity (EASO) and the Novo Nordisk Foundation (NNF) announced that they were establishing a new prize for an agenda-setting researcher
Nordic Life Science
The latest clinical trials
Guard Therapeutics has announced top-line results from its AKITA study, evaluating RMC-035 for the prevention of kidney injury in open-heart surgery. Patient recruitment was prematurely stopped, and as expected the
Genmab and Seagen have announced that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who received
The 15th patient with advanced hepatocellular carcinoma (HCC) has been included in the company’s ongoing phase 2a study. The study evaluates safety and efficacy with the candidate drug fostrox in
Herantis Pharma has announced that the dosing of the healthy volunteers in part 2 of the Phase 1a clinical study has been started based on decision from the Data and
Calliditas Therapeutics has announced publication in The Lancet of the full data from the Phase 3 NefIgArd Study with Nefecon in adults with Primary IgA nephropathy (IgAN). The Phase 3
Annexin Pharmaceuticals has announced that an independent evaluation of potential signals of effect has been carried out in the company’s Phase 2-study in retinal vein occlusion with the investigational new
Ultimovacs has announced the completion of enrollment of 75 patients and that the last patient has received the first dose in the FOCUS study. “We are pleased to announce the
Bavarian Nordic has announced topline results from a randomized, double-blind, placebo-controlled Phase 3 clinical trial of its virus-like particle (VLP)-based chikungunya virus vaccine candidate, CHIKV VLP, in adults and adolescents
Alligator Bioscience has announced positive second interim results from the ongoing OPTIMIZE-1 Phase 2 study of the company’s lead asset mitazalimab in 1st line metastatic pancreatic cancer. The open-label, multi-center
Sign up to our newsletter